Rafael Holdings Inc Revenue Growth Rates (RFL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rafael Holdings Inc  (NYSE: RFL)
 

RFL's Revenue Growth by Quarter and Year

Rafael Holdings Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RFL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter July -
3rd Quarter April 0.18
2nd Quarter January 0.24
1st Quarter October 0.35
FY 0.77

RFLs Annual Revenue
Rafael Holdings Inc's Revenue in the fiscal year 2026 $ 0.21 millions
Rafael Holdings Inc's Revenue in the fiscal year 2025 $ 0.92 millions
Rafael Holdings Inc's Revenue in the fiscal year 2024 $ 0.64 millions
Rafael Holdings Inc's Revenue in the fiscal year 2023 $ 0.28 millions
Rafael Holdings Inc's Revenue in the fiscal year 2022 $ 0.41 millions




RFL Revenue third quarter 2026 Y/Y Growth Comment
Rafael Holdings Inc achieved in the third quarter 2026, above Company average Revenue surge of 123.75% year on year, to $ 0.18 millions.

Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Revenue growth. While Rafael Holdings Inc' s Revenue doubling of 123.75% ranks overall at the positon no. 270 in the third quarter 2026.


RFL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter July - 5.88 % 385.71 % -12.5 %
3rd Quarter April 123.75 % 14.29 % 0 % 0 %
2nd Quarter January 84.62 % 85.71 % 0 % -63.16 %
1st Quarter October 105.88 % 142.86 % 0 % -92.78 %
FY   - 34.55 % 96.43 % -

Financial Statements
Rafael Holdings Inc's third quarter 2026 Revenue $ 0.18 millions RFL's Income Statement
Rafael Holdings Inc's third quarter 2025 Revenue $ 0.08 millions Quarterly RFL's Income Statement


RFL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter July - 350 % 385.71 % 0 %
3rd Quarter April -25.42 % -38.46 % 0 % 0 %
2nd Quarter January -31.43 % -23.53 % 0 % 0 %
1st Quarter October -2.78 % -50 % 0 % -12.5 %
FY (Year on Year)   - 34.55 % 96.43 % -


Back to RFL Growth rate Comparisons >> Back to RFL Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #42
Healthcare Sector #79
Overall #270

Revenue Y/Y Growth Statistics
High Average Low
231.05 % -13673.43 % -65996.17 %
(Jul 31 2025)   (Oct 31 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #42
Healthcare Sector #79
Overall #270
Revenue Y/Y Growth Statistics
High Average Low
231.05 % -13673.43 % -65996.17 %
(Jul 31 2025)   (Oct 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Rafael Holdings Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
394.12 % 12.88 % -92.11 %
(Apr 30 2024)  


RFL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Rafael Holdings Inc disclosed fall in Revenue from the second quarter by -25.42% to $ 0.18 millions, from $ 0.24 millions achived in the previous reporting period.

But that's not important problem, as Rafael Holdings Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Revenue quarter on quarter growth. While Rafael Holdings Inc's Revenue growth quarter on quarter, overall rank is 3340.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #467
Overall #3340
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #467
Overall #3340
Revenue Q/Q Growth Statistics
High Average Low
394.12 % 12.88 % -92.11 %
(Apr 30 2024)  


RFL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Rafael Holdings Inc disclosed fall in Revenue from the second quarter by -25.42% to $ 0.18 millions, from $ 0.24 millions achived in the previous reporting period.

But that's not important problem, as Rafael Holdings Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Revenue quarter on quarter growth. While Rafael Holdings Inc's Revenue growth quarter on quarter, overall rank is 3340.


Rafael Holdings Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 30 2026)		 12 Months Ending
(Oct 31 2025)		 12 Months Ending
(Oct 31 2025)		 12 Months Ending
(Jul 31 2025)		 12 Months Ending
(Apr 30 2025)
Cumulative Revenue 12 Months Ending $ 1.13 $ 0.77 $ 1.03 $ 0.92 $ 0.73
Y / Y Revenue Growth (TTM) 60.2 % 10.47 % 47.63 % 43.96 % 35.56 %
Year on Year Revenue Growth Overall Ranking # 66 # 0 # 52 # 54 # 51
Seqeuential Revenue Change (TTM) 9.91 % 17.02 % 12.21 % 25.27 % 3.68 %
Seq. Revenue Growth (TTM) Overall Ranking # 270 # 0 # 1105 # 113 # 2260


Cumulative Revenue growth Comment
Rafael Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 60.2% year on year, to $ 1 millions if the fiscal year would have ended in Apr 30 2026.
Rafael Holdings Inc's trailing twelve months Revenue growth was higher than company's average -13673.43% and higher than 10.47% growth in Oct 31 2025.
But from twelve months ended Oct 31 2025 rise was beneth at 9.91 % from $1.03 millions achieved in the period from Oct 31 2025 to Apr 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -13673.43%.
The momentum is even more impressive from twelve months ended Oct 31 2025 exhibited at 9.91 % increase from $1.03 millions in the period from Oct 31 2025 to Apr 30 2025.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 66.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 23
Overall # 66

Revenue TTM Y/Y Growth Statistics
High Average Low
231.05 %
 -13673.43 %
-65996.17 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 79
S&P 500 # 270
Cumulative Revenue growth Comment
Rafael Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 60.2% year on year, to $ 1 millions if the fiscal year would have ended in Apr 30 2026.
Rafael Holdings Inc's trailing twelve months Revenue growth was higher than company's average -13673.43% and higher than 10.47% growth in Oct 31 2025.
But from twelve months ended Oct 31 2025 rise was beneth at 9.91 % from $1.03 millions achieved in the period from Oct 31 2025 to Apr 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -13673.43%.
The momentum is even more impressive from twelve months ended Oct 31 2025 exhibited at 9.91 % increase from $1.03 millions in the period from Oct 31 2025 to Apr 30 2025.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 66.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 23
Overall # 66

Revenue TTM Y/Y Growth Statistics
High Average Low
231.05 %
-13673.43 %
-65996.17 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 79
S&P 500 # 270




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RFL's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Apr 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 30 2026
Zeo Scientifix Inc 124.63%$ 124.630 millions
Kestra Medical Technologies Ltd 66.18%$ 66.181 millions


About Rafael Holdings Inc Revenue Growth Rates (RFL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rafael Holdings Inc (CIK 1713863).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-067560
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rafael Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.